Concepedia

Feng Ren

FR

60

Publications

2.4K

Citations

27

H-Index

1992

Active since

Affiliations

GlaxoSmithKline (China)(Current)

Hong Kong Science and Technology Parks Corporation

Insilicos (United States)

Kyoto Institute of Technology

Buck Institute for Research on Aging

Feng Ren is an author at GlaxoSmithKline (China) specializing in engineering, chemistry, and drug discovery.

ORCID

Top concepts

Publications per year

1992–2025

60

Publications

60

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Feng Ren, Xiao Ding, Min Zheng et al. · Chemical Science · 2023 · 292 citations · Full text

A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · 219 citations · Full text

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization

Yan A. Ivanenkov, Daniil Polykovskiy, Dmitry S. Bezrukov et al. · Journal of Chemical Information and Modeling · 2023 · 174 citations · Full text

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery

Petrina Kamya, Ivan V. Ozerov, Frank W. Pun et al. · Journal of Chemical Information and Modeling · 2024 · 108 citations · Full text

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Frank W. Pun, Bonnie Hei Man Liu, Xi Long et al. · Frontiers in Aging Neuroscience · 2022 · 91 citations · Full text

Rows per page

1–5 of 60